Panacea Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PANACEA, and what generic and branded alternatives to PANACEA drugs are available?
PANACEA has three approved drugs.
Summary for Panacea
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| PTAB Cases with Panacea as petitioner: | See PTAB cases with Panacea as petitioner |
Drugs and US Patents for Panacea
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panacea | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 204722-001 | Jan 11, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Panacea | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 204722-002 | Jan 11, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Panacea | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 090802-001 | Sep 28, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Panacea | PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205897-002 | Oct 16, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Panacea | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 090802-003 | Sep 28, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Panacea | PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205897-001 | Oct 16, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Panacea | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 090802-002 | Sep 28, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
